Should These Be On Your List Of Penny Stocks To Buy?
Trading penny stocks is simple in theory. You find cheap shares, hit the buy button on your broker platform, then sell when your profit target is reached. However, when it comes to finding the top penny stocks to buy, a lot more effort goes into it than just knowing how to buy or when to sell. Research is key, and understanding volatility is important.
The definition of penny stocks refers to shares of companies trading under $5. With this as the backdrop, share price alone can make for a volatile situation in the market. Think about it. Even with the highest-priced penny stock, a 50 cent move still equates to a noticeable gain. The lower the price, the less movement needed to realize meaningful gains.
This is one of the main reasons new traders choose penny stocks to buy in the first place. Even a $500 position can produce a much larger windfall in a shorter time frame compared to purchasing shares of Netflix (NASDAQ: NFLX) or Amazon (NASDAQ: AMZN). But there is a downside, of course. Not all penny stocks go up. Also, the ones that do climb don’t move higher in a straight line. Even if you’re learning about investing, penny stocks are usually not the first type of asset to choose. This is simply due to the higher level of volatile price action these typically see.
Penny Stocks To Buy On Robinhood
Here’s where new trends take hold. The Reddit community has now become the poster for retail traders. Earlier this year, Redditors across multiple subreddits like r/WallStreetBets and r/PennyStocks rallied behind certain companies. GameStop (NYSE: GME), Express (NYSE: EXPR), and Nokia (NYSE: NOK) are just a few names that took flight during the 2021 short-squeeze frenzy.
Also, the broker of choice among these retail traders seems to have been Robinhood. It’s easy to use and simple to place trades with. But it also comes with its own downside. Not all penny stocks are accessible on it. With few exceptions, OTC penny stocks can’t be purchased on the platform. Does this mean it’s a lost cause if you’re trading penny stocks? Of course not.
But the amount of stocks under $1 is relatively limited compared to other brokers like ETrade or Fidelity. Needless to say, we’ve found a few that have been trending recently and have also become some of the more actively discussed penny stocks on Reddit. Will they be on your buy or avoid list this week?
- Oragenics Inc. (NYSE: OGEN)
- AIkido Pharma Inc. (NASDAQ: AIKI)
- Kelso Technologies Inc (NYSE: KIQ)
- Brickell Biotech, Inc. (NASDAQ: BBI)
Reddit Penny Stocks To Buy [or avoid] #1: Oragenics Inc. (NYSE: OGEN)
Oragenics was a big mover earlier in the year. Shares of OGEN stock surged from under 50 cents to highs of $1.80 within a few weeks. The big catalyst behind the move stemmed from Oragenics’ potential COVID-19 vaccine, Terra CoV-2. The company raised some capital which triggered a sell-off in February, but it recovered early last month. That was when the company entered into a material transfer agreement with Biodextris Inc. This was for the use of three intranasal mucosal adjuvants in Terra CoV-2.
These adjuvants are added to vaccines to enhance their immunogenicity. Biodextris’ BDX100, BDX300, and BDX301 offered an additional immune response, manufacturing efficiency, and intranasal vaccine administration benefits.
Obviously, you’ll see that most of April was reminiscent of February in that OGEN stock had slid lower. But late last week, the tides turned. Shares rallied over 40% from Wednesday to Friday. There wasn’t any formal news or a filing to pair with the move. However, the speculative nature surrounding pandemic penny stocks remains a focus. With rising cases globally, OGEN stock could be one to watch after last week’s late rally.
2. AIkido Pharma Inc. (NASDAQ: AIKI)
Another one of the niches in the stock market gaining attention recently is biotech companies targeting the central nervous system (CNS) and mental health disorders. AIkido announced earlier this month that it was granted an exclusive sublicense to technology related to proprietary CNS homing peptides to treat neuroinflammatory disease in cancer patients.
But CNS is just one facet of AIkido’s treatment platform. The center point of its pipeline focuses on cancer. It includes therapies for pancreatic cancer and prostate cancer. The company is also developing a broad-spectrum antiviral platform that could inhibit replication of multiple viruses, including the Influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus.
In its latest update, Anthony Hayes, CEO of AIkido Pharma, explained, “Recent advancements from our research partners and the anticipated publication of testing data for our technology that is expected in the second quarter of this year, reinforce our optimism around the opportunities for our therapeutic drug platform and the future of the Company. Through a series of recent financing transactions, we believe we are sufficiently capitalized to fund research activities that are currently underway and selectively pursue additional emerging opportunities.”
With this being the second quarter of the year, the publication of testing data for its technology is becoming a stronger focus. While no firm dates were given, any new pharmaceutical developments can become potential catalysts.
3. Kelso Technologies Inc (NYSE: KIQ)
Shares of Kelso Technologies mirrored a similar move that OGEN saw last week. The penny stock rallied from Wednesday through Friday, jumping nearly 19%. No news or filings came out to pair with the move. However, from a technical perspective, we can see that the 200-day moving average acted as an area of support on the chart. This was the first time since January that KIQ stock tested this technical level, and it once again managed to bounce off of it by Friday’s closing bell.
[Read More] Biotech Penny Stocks To Buy? 3 to Watch Under $5
Kelso specializes in the production and distribution of service equipment used in transportation applications. This includes designing and supplying high-quality rail tank car valve equipment. These allow for the safe handling and containment of hazardous and non-hazardous materials.
Regardless of there not being any recent headlines, there may be a “reopening” angle to pay attention to. With manufacturing and commerce getting a reboot after the pandemic, related companies could have gained some sympathy momentum. Obviously, transportation via rail could pick up with the overall economic reopening. With that, countless companies that are part of the business ecosystem for this transport method could stand to benefit. Whether or not that is or will be what Kelso experiences is yet to be seen. However, based on last week’s rally, it could be one of the penny stocks on Robinhood to watch this week.
4. Brickell Biotech, Inc. (NASDAQ: BBI)
Last week was an active one for Brickell Biotech. The latest 3-day rally that mimicked the trends of OGEN and KIQ also came on the heels of big news from the company. Brickell Biotech announced results from its Phase 3 open-label, long-term safety study (ARGYLE or LTSS). These were also presented in a late-breaking oral presentation at the American Academy of Dermatology’s Virtual Meeting Experience.
According to the company, the ARGYLE study weighed the long-term safety and efficacy of topical, once-daily treatment with Brickell’s sofpironium bromide gel. This is for patients nine years and older with primary axillary hyperhidrosis or excessive underarm sweating.
The data contributed to understanding the long-term use of sofpironium bromide gel as a potential treatment for this condition. Stacy Smith, MD, a practicing dermatologist and participating investigator in this study, said, “Taking into consideration that patients did not have the conventional option to acclimate to treatment prior to enrolling in this standalone long-term safety study, the observed safety profile is even more encouraging.”
In addition to the presentation on April 23rd, Brickell also hosted a Q&A session on the 24th. Since this was over the weekend, it will be interesting to see if any new details emerged at the meeting come Monday morning.